Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;20(9):2851-2857.
doi: 10.31557/APJCP.2019.20.9.2851.

Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes

Rowida Almomani  1 , Mariam Khanfar  1 , Khaldon Bodoor  2 , Firas Al-Qarqaz  3 , Mohammad Alqudah  4 , Hanan Hammouri  5 , Asma Abu-Salah  4 , Yazan Haddad  2 , Wisam Al Gargaz  6 , Ziyad Mohaidat  6
Affiliations

Evaluation of Patched-1 Protein Expression Level in Low Risk and High Risk Basal Cell Carcinoma Subtypes

Rowida Almomani et al. Asian Pac J Cancer Prev. .

Abstract

Objective: Basal cell carcinoma (BCC) is the most common malignancy in humans and represents a growing public health care problem. The major etiological factors contributing to BCC development are exposure to ultraviolet radiation and genetic alterations. BCC is primarily caused by dysregulation of sonic Hedgehog (HH) signaling pathway in basal cells of the skin. BCC can be classified into low risk non-aggressive and high risk aggressive subtypes. BCC subtypes differentiation is essential for prognosis and for better disease management and treatment strategies. The aim of this study was to assess the correlation between PTCH1 protein expression level and the aggressiveness of BCC histopathology. Methods: Archival paraffin embedded blocks containing BCC were retrieved from a cohort of 101 patients. Immunohistochemistry staining was performed to assess the expression level of PTCH1 which is a key component of Hedgehog pathway. Results: 101 paraffin embedded samples were evaluated and classified as high risk and low risk BCC subtypes by histopathological finding. High risk BCC subtypes were found in 40 samples (39.6%) and low risk subtypes were identified in 61 samples (60.4%). Nodular was the most frequent subtype which was found in (56/ 101), followed by infiltrative (22/101) and micronodular (14/ 101) subtypes. Positive PTCH1 expression was found highest in nodular subtypes (46.5%). Conclusion: In this study, the correlation between low risk or high risk BCC subtypes and PTCH1 expression level was not statistically significant (p>0.05), but the frequency of positive PTCH1 expression was found to be higher in low risk subtypes than high risk BCC subtypes.

Keywords: Basal cell carcinoma; PTCH1; high risk BCC; low risk BCC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of Histopathological Subtypes of BCC
Figure 2
Figure 2
Immunohistochemistry Staining Results of PTCH1 Expression. A, shows strong PTCH1 expression while B shows a negative staining of PTCH1
Figure 3.
Figure 3.
Distribution of PTCH1 Expression Age, Sex, Across Several Variables
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Adolphe C, Hetherington R, Ellis T, Wainwright B. Patched1 functions as a gatekeeper by promoting cell cycle progression. Cancer Res. 2006;66:2081–8. - PubMed
    1. Al-Qarqaz F, Marji M, Bodoor K, et al. Clinical and demographic features of basal cell carcinoma in north Jordan. J Skin Cancer. 2018;2018:2624054. - PMC - PubMed
    1. Al-Qarqaz F, Bodoor K, Al-Tarawneh A, et al. Basal cell carcinoma pathology requests and reports are lacking important information. J Skin Cancer. 2019;2019:4876309. - PMC - PubMed
    1. Arits A H, Schlangen M H, Nelemans P J, Kelleners-Smeets NW. Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol. 2011;25:565–9. - PubMed
    1. Aszterbaum M, Rothman A, Johnson R.L, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 1998;110:885–8. - PubMed